en

PRODUCT DETAIL

VEGZELMA 25 mg/ml infúzny koncentrát

Code 1915E
MA number EU/1/22/1667/002
Product Form: con inf 1x16 ml/400 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01FG VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors
L01FG01 Bevacizumab
Shelf life: 48
Container: glass vial
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 17.08.2022
Validity: 17.08.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 23.08.2022
eu-flag.png sk-flag.png